SEC Form D private-offering filing

Qlaris Bio, Inc.

Name: Qlaris Bio, Inc. - new SEC Form D private-offering filing, Dedham, MA
Published: 2025-11-17

A new SEC Form D private-offering notice from Dedham, MA, a $5,641,600 filer-stated offering target in Biotech. The source filing is one click away.

Qlaris Bio, Inc. site↗ Verified via SEC Form D

Clinical-stage biotech developing QLS-111, a topical drug candidate to lower intraocular pressure and treat glaucoma

Filed 2025-11-17Filed to raise $5,641,600First money in 2025-11-13Raised so far $5,641,600HQ (as filed) Dedham, MASector Biotech ✓Stage (inferred) EarlyCall status Call-ready

Source linked the Form D on EDGAR↗Website verified qlaris.bio↗Named in the filing 6 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.